Abstract
To compare the blood pressure (BP)-lowering effects of telmisartan 40 mg/day and hydrochlorothiazide (HCTZ) 25 mg/day in high sodium intake patients with mild-to-moderate hypertension in China. In this randomized, double-blind trial, eligible patients were randomly divided into telmisartan and HCTZ groups with three follow-ups scheduled on days 15, 30, and 60 after enrollment to compare BP decrease, hypokalemia, and other adverse events after intervention. A total of 1333 mild-to-moderate hypertensive patients with average sodium intake of 5909 mg/day were enrolled from 14 county hospitals in China. Baseline characteristics were well balanced. At 15, 30, and 60 days of follow-up, average SBP/DBP reduction in telmisartan and HCTZ group was 12.5/8.0, 14.3/9.1, 12.8/7.2, 11.0/5.8, 13.6/7.1, and 11.5/5.3 mmHg, respectively. Telmisartan showed greater BP response than HCTZ at three visits, with statistical significance for DBP (P < 0.001) regardless of the adjustment for baseline BP, sodium excretion, and pulse pressure (PP). SBP reduction was positively related to increasing urinary sodium and PP levels for patients in both groups but increased faster with increasing PP in HCTZ than in telmisartan (P = 0.0238 for group × PP). Compa...Continue Reading
References
Apr 19, 1986·Lancet·A HelgelandS Tretli
Oct 12, 1999·Journal of Human Hypertension·J MallionY Lacourcière
Feb 15, 2001·Circulation·M Burnier
Oct 20, 2001·Hypertension·W C CushmanD J Reda
Mar 10, 2004·Hypertension·Stephen C BensonTheodore W Kurtz
Dec 25, 2004·International Journal of Clinical Practice. Supplement·J R ZhuN N Cheng
Jan 10, 2006·Drugs·Anna J Battershill, Lesley J Scott
Feb 29, 2008·Journal of Human Hypertension·C-C HuangJ-W Chen
Jul 17, 2008·Nature Clinical Practice. Cardiovascular Medicine·Theodore W Kurtz
Jul 22, 2009·Hypertension·Eduardo PimentaDavid A Calhoun
Apr 8, 2010·Diabetologia·E I EkinciG Jerums
May 1, 2010·Journal of the American Dietetic Association·Cheryl A M AndersonJeremiah Stamler
Jun 10, 2010·Expert Review of Cardiovascular Therapy·Julio D Duarte, Rhonda M Cooper-DeHoff
Jan 26, 2011·Optics Express·Jingbo WuPeiheng Wu
Apr 25, 2012·Hypertension·George C RoushAchuta K Guddati
May 2, 2012·Hypertension·Mark A PeterzanAlun D Hughes
Sep 5, 2014·Journal of Hypertension·Nagako OkudaUNKNOWN INTERMAP Research Group
Jan 23, 2015·Journal of Integrative Medicine·Vamsi ReddyJiwang Chen
Mar 4, 2015·Hypertension·George C RoushDomenic A Sica
May 1, 2015·American Journal of Hypertension·Peng ChenDao Wen Wang
May 27, 2015·American Journal of Hypertension·Weizhong HanZhiyi Ma
Jun 8, 2015·Current Opinion in Cardiology·Wanpen Vongpatanasin
Sep 17, 2015·Medicine·Xiaoqin CaoKaijuan Wang
Apr 7, 2016·American Journal of Hypertension·George C Roush, Domenic A Sica
Dec 10, 2016·PloS One·Nicole LiBruce Neal